LTFS
AST.WS

Ladenburg Thalmann Financial Services’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-142
Closed – – 5232
2017
Q2 		$0 Hold
142
– – ﹤0.01% 5177
2017
Q1 		$0 Buy
142
+8
+6% +$3 ﹤0.01% 5179
2016
Q4 		$0 Hold
134
– – ﹤0.01% 5148
2016
Q3 		$0 Hold
134
– – ﹤0.01% 5101
2016
Q2 		$0 Buy
+134
New +$70 ﹤0.01% 5081

Ladenburg Thalmann Financial Services's AST.WS Position: Q3 2017 in Review

Ladenburg Thalmann Financial Services sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 142 shares.

Ladenburg Thalmann Financial Services first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 142 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • Ladenburg Thalmann Financial Services first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Ladenburg Thalmann Financial Services's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2017, filed 15 Nov 2017.